OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current strategies against persistent human papillomavirus infection (Review)
Yu Liu, Hongyi Li, Ruyu Pi, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 19
Yu Liu, Hongyi Li, Ruyu Pi, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 19
Showing 19 citing articles:
The role of lipids and lipids lowering drugs in human papillomavirus (HPV) and HPV-associated cancers
Ehsan Shabani, Aida Hasanzadi, Omer Qutaiba B. Allela, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Ehsan Shabani, Aida Hasanzadi, Omer Qutaiba B. Allela, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
CRISPR‐Cas system for biomedical diagnostic platforms
Zhen Wang, Wenguo Cui
View (2020) Vol. 1, Iss. 3
Open Access | Times Cited: 30
Zhen Wang, Wenguo Cui
View (2020) Vol. 1, Iss. 3
Open Access | Times Cited: 30
Current Status of Human Papillomavirus Infection and Cervical Cancer in the Philippines
Ryan C. V. Lintao, Leslie Faye T. Cando, Glenmarie Angelica S. Perias, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 18
Ryan C. V. Lintao, Leslie Faye T. Cando, Glenmarie Angelica S. Perias, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 18
The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics
Janice García‐Quiroz, Bismarck Vázquez-Almazán, Rocio Garcı́a-Becerra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2528-2528
Open Access | Times Cited: 18
Janice García‐Quiroz, Bismarck Vázquez-Almazán, Rocio Garcı́a-Becerra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2528-2528
Open Access | Times Cited: 18
Prevalence and genotype distribution of HPV and cervical pathological results in Sichuan Province, China: a three years surveys prior to mass HPV vaccination
Qing Luo, Ni Jiang, Qiaoyuan Wu, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Qing Luo, Ni Jiang, Qiaoyuan Wu, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses
Prashant Chauhan, Sreepoorna Pramodh, Arif Hussain, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Prashant Chauhan, Sreepoorna Pramodh, Arif Hussain, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Stability analysis and optimal control of HPV infection model with early-stage cervical cancer
Karam Allali
Biosystems (2020) Vol. 199, pp. 104321-104321
Closed Access | Times Cited: 18
Karam Allali
Biosystems (2020) Vol. 199, pp. 104321-104321
Closed Access | Times Cited: 18
Impact of Dietary Quality on Genital Oncogenic Human Papillomavirus Infection in Women
Hui‐Yi Lin, Qiufan Fu, Tung‐Sung Tseng, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 10, pp. 1385-1393
Open Access | Times Cited: 5
Hui‐Yi Lin, Qiufan Fu, Tung‐Sung Tseng, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 10, pp. 1385-1393
Open Access | Times Cited: 5
REBACIN® inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
Shu‐Guang Zhou, Dai-Fei Wu, Hui Yao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Shu‐Guang Zhou, Dai-Fei Wu, Hui Yao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Physiopathology and effectiveness of therapeutic vaccines against human papillomavirus
Ayesha Noor, Sara Aboulaghras, Muhammad Jahangeer, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 35, pp. 47752-47772
Open Access | Times Cited: 11
Ayesha Noor, Sara Aboulaghras, Muhammad Jahangeer, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 35, pp. 47752-47772
Open Access | Times Cited: 11
Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Trends in cocirculation of oncogenic HPV genotypes in single and multiple infections among the unvaccinated community
Manijheh Vazifehdoost, Fatemeh Eskandari, Amir Sohrabi
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3376-3385
Open Access | Times Cited: 6
Manijheh Vazifehdoost, Fatemeh Eskandari, Amir Sohrabi
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3376-3385
Open Access | Times Cited: 6
Bioactive Phytochemicals as Potential Strategies for Human Papillomavirus Inhibition and Clinical Therapy: Molecular Mechanisms and Application Prospects
Xingyuan Wu, Weijie Zhou, Yue Li, et al.
(2024)
Closed Access
Xingyuan Wu, Weijie Zhou, Yue Li, et al.
(2024)
Closed Access
Improvement of therapy of papillomavirus infection latent forms
D.A. Abukhaltam Akhmad, И.В. Полеско, А. А. Халдин, et al.
Russian Journal of Clinical Dermatology and Venereology (2024) Vol. 23, Iss. 5, pp. 575-575
Closed Access
D.A. Abukhaltam Akhmad, И.В. Полеско, А. А. Халдин, et al.
Russian Journal of Clinical Dermatology and Venereology (2024) Vol. 23, Iss. 5, pp. 575-575
Closed Access
Prevalence and genotype distribution of HPV and cervical pathological results in Sichuan Province, China: a three years surveys prior to mass HPV vaccination
Qing Luo, Ni Jiang, Qiaoyuan Wu, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 2
Qing Luo, Ni Jiang, Qiaoyuan Wu, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 2
Human Papillomavirus (HPV) Entry Inhibitors
Yun Zhu
Advances in experimental medicine and biology (2022), pp. 223-239
Closed Access | Times Cited: 1
Yun Zhu
Advances in experimental medicine and biology (2022), pp. 223-239
Closed Access | Times Cited: 1
Promising directions in the development of new vaccines against papillomavirus infection
Tatiana N. Nikitina, Natalya M. Rayevskaya, Irina L. Solovieva, et al.
Cytokines and inflammation (2023) Vol. 20, Iss. 1, pp. 32-40
Closed Access
Tatiana N. Nikitina, Natalya M. Rayevskaya, Irina L. Solovieva, et al.
Cytokines and inflammation (2023) Vol. 20, Iss. 1, pp. 32-40
Closed Access
A case of synchronous high‐grade cervical intraepithelial neoplasia and metastatic squamous cell carcinomas of unknown primary in rectum
Syunsuke Orisaka, Mitsuhiro Nakamura, Takeshi Obata, et al.
Journal of Obstetrics and Gynaecology Research (2021) Vol. 47, Iss. 7, pp. 2555-2559
Closed Access
Syunsuke Orisaka, Mitsuhiro Nakamura, Takeshi Obata, et al.
Journal of Obstetrics and Gynaecology Research (2021) Vol. 47, Iss. 7, pp. 2555-2559
Closed Access
